ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Convergence

Reflections on B Cells in SLE & Lupus Nephritis

Ruth Jessen Hickman, MD  |  October 30, 2025

At the Dubois Memorial Lecture presented at ACR Convergence 2025, Shaun Jackson, MD, PhD, discussed the evolving understanding of the role of B cells in SLE.

ACR Convergence 2025, Chicago. Video highlights

ACR Convergence 2025: Video Highlights

From the College  |  October 30, 2025

Dr. Tait Shanafelt, with ACR President Dr. Carol Langford

Burnout Requires Attention, Advocacy for Research & More

Vanessa Caceres  |  October 30, 2025

This year’s Opening Session of ACR Convergence 2025 featured a well-known thought leader on physician burnout, Dr. Tait Shanafelt, who provided insight into the risk of burnout and how to prevent it. Key leadership also addressed research advocacy and more.

From Conceptual Seedling to Tree of Knowledge

Jason Liebowitz, MD, FACR  |  October 30, 2025

In a panel discussion at ACR Convergence 2025, three experts provided insight into how mentorship, personal values and more helped them develop the skills and habits necessary to become a master clinician.

Updates on Fibromyalgia & the Quest to Alleviate Pain

Jason Liebowitz, MD, FACR  |  October 29, 2025

ACR Convergence 2025 speakers reviewed new fibromyalgia insights, from the first new drug approval since 2009 to nociplastic pain concepts & cognitive behavioral therapy.

Emerging Treatments in Psoriatic Arthritis

Ruth Jessen Hickman, MD  |  October 29, 2025

At a scientific session of ACR Convergence 2025, Alexis Ogdie, MD, discussed new and forthcoming treatments for psoriatic arthritis.

Meet Incoming ARP President Rebecca Cleveland

Leslie Mertz, PhD  |  October 29, 2025

Incoming ARP President Dr. Rebecca Cleveland discusses her plans for advocacy, ACR/ARP collaboration, & tackling workforce shortages in rheumatology.

Meet New ACR President William (Will) F. Harvey

Leslie Mertz, PhD  |  October 29, 2025

Incoming ACR President Will Harvey shares his strategy for fighting reimbursement cuts, funding threats & workforce shortages through advocacy & member engagement.

Let’s Discuss Part 2: More Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 28, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on cutaneous manifestations of rheumatic diseases, gout, macrophage activation syndrome and vasculitis.

Gout & Cardiometabolic Co-Morbidities

Jason Liebowitz, MD, FACR  |  October 28, 2025

ACR Convergence 2025 experts explore gout’s deep ties to MetS, insulin resistance and cardiovascular mortality, weighing new data on colchicine, febuxostat and SGLT2 inhibitors.

  • 1
  • 2
  • 3
  • …
  • 38
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences